biomedicina slovenica


pr=Bergant : 101-200

  1. Repnik U; Bergant M; Jeras M
    Lastnosti in možnosti uporabe dendritičnih celic, antigensko specifičnih modulatorjev imunskega odziva
    2004
  2. Bergant D; Hočevar M
    Medulllary thyroid carcinoma. Genetic screening and prophylactic thyroidectomies
    2003
  3. Bešić N; Žgajnar J; Bergant D; Hočevar M; Pompe F
    Prognostic factors in follicular and Huerthle cell carcinoma of the thyroid gland - a multivariate survival analysis
    2003
  4. Bergant D; Glavač D; Bešić N; Hočevar M
    Medullary thyroid carcinoma (MTC): genetic screening in Slovenia 1997-2002
    2003
  5. Mulaomerović Adaleta; Berbić-Fazlagić Jasmina; Sekirnik Andreja; Zavašnik-Bergant Valentina; Kos Janko; Begić Lejla
    Cathepsins X, S and cystatin C in sera of patients with B-cell lymphoma
    2004
  6. Langerholc Tomaž; Zavašnik-Bergant Valentina; Turk Vito; Abrahamson Magnus; Kos Janko
    Unusual localization and inhibitory properties of cystain F in U937 cells
    2004
  7. Cegnar Mateja; Premzl Aleš; Zavašnik-Bergant Valentina; Kristl Julijana; Kos Janko
    Passive targeting of cysteine protease inhibitor cystatin into tumour cells by using poly(lactide-co-glycolide) nanoparticles
    2004
  8. Bergant Martina; Repnik Urška; Sojar Valentin; Stanisavljevič Dragan; Štabuc Borut; Jeras Matjaž
    Induction of cytotoxic T cell responses in vitro using monocyte derived dendritic cells pulsed with tumor lysates or transfected with total tumor cell RNA
    2004
  9. Zavašnik-Bergant Valentina; Mulaomerović Adaleta; Repnik Urška; Sekirnik Andreja; Langerholc Tomaž; Begić Leila; Jeras Matjaž; Golouh Rastko; Turk Vito; Kos Janko
    Cystatin C in non-Hodgkin lymphoma patients: possible relation to anti-tumour immune response
    2004
  10. Auersperg M; Pogačnik A; Čemažar M; Bešić N; Pompe F; Brecelj E; Bergant D; Hočevar M
    Rational planning of initial chemotherapy in anaplastic thyroid carcinoma
    2004
  11. Repnik Urška; Bergant Martina; Jeras Matjaž
    Lastnosti in možnosti uporabe dendritičnih celic, antigensko specifičnih modulatorjev imunskega odziva
    [Characteristics and potential therapeutic applications of dendritic cells, antigen specific modulators of immune responses]
    2004
  12. Bergant Damijan; Pfeifer Marija
    Multipla endokrina neoplazija 2A (MEN 2A) - prikaz primera z rezultati genetskega presejanja družine
    2003
  13. Cegnar Mateja; Premzl Aleš; Zavašnik-Bergant Valentina; Kristl Julijana; Kos Janko
    Effect of polymer type on the activity of cystatin encapsulated in poly(lactide-co-glycolide) nanoparticles and their uptake in MCF-10A neoT cells
    2003
  14. Premzl Aleš; Zavašnik-Bergant Valentina; Turk Vito; Kos Janko
    Intracellular and extracellular cathepsin B facilitate invasion of MCF-10A neoT cells through reconstituted extracellular matrix in vitro
    2003
  15. Zavašnik-Bergant Valentina; Sekirnik Andreja; Golouh Rastko; Turk Vito; Kos Janko
    Immunochemical localisation of cathepsin S, cathepsin L and MHC class II-associated p41 isoform of invariant chain in human lymph node tissue
    2001
  16. Premzl Aleš; Puizdar Vida; Zavašnik-Bergant Valentina; Kopitar-Jerala Nataša; Lah Tamara; Katunuma N; Sloane BF; Turk Vito; Kos Janko
    Invasion of ras-transformed breast epithelial cells depends on the proteolytic activity of cysteine and aspartic proteinases
    2001
  17. Zavašnik-Bergant V
    Vloga oblike p41 invariantne verige in cistatina C pri uravnavanju cisteinskih proteaz v antigen predstavitvenih celicah
    [Role of p41 isoform of invariant chain and cystatin C regulating cysteine proteases in antigen-presenting cells]
    2003
  18. Bergant Otmar
    Prim. dr. Dušan Reja, dr. med.: (1908-1980)
    2002
  19. Kos Janko; Premzl Aleš; Zavašnik-Bergant Valentina; Sekirnik Andreja; Schweiger Ana; Langerholc Tomaž; Kopitar-Jerala Nataša; Malovrh Tadej
    Proteolytic system in diagnosis and therapy of cancer
    2003
  20. Cegnar Mateja; Premzl Aleš; Zavašnik-Bergant Valentina; Kristl Julijana; Kos Janko
    Poly(lactide-co-glycolide) nanoparticles as a carrier system for delivery of cysteine proteases inhibitor cystatin into tumour cells
    2003
  21. Langerholc Tomaž; Zavašnik-Bergant Valentina; Repnik Urška; Turk Vito; Abrahamson Magnus; Kos Janko
    The role of cystatin F in human haematopoietic cells
    2003
  22. Zavašnik-Bergant Valentina; Repnik Urška; Schweiger Ana; Romih Rok; Jeras Matjaž; Turk Vito; Kos Janko
    Differentiation and maturation dependent content, localization and extracellular secretion of cystatin C in human dendritic cells
    2003
  23. Korošec B; Caserman S; Bergant D; Ravnik-Glavač M; Glavač D
    Mutational analyses of the ret proto-oncogene in Slovenian Men2 families
    2001
  24. Korošec B; Caserman S; Bergant D; Ravnik-Glavač M; Glavač D
    Mutational analyses of the RET proto-encogene in Slovenian MEN2 families
    2003
  25. Zavašnik-Bergant Valentina; Repnik Urška; Schweiger Ana; Langerholc Tomaž; Romih Rok; Jeras Matjaž; Turk Vito; Kos Janko
    Role of p41 isoform of invariant chain and cystatin C in human lymph nodes and dendritic cells
    2003
  26. Zavašnik-Bergant Valentina
    Vloga oblike p41 invariantne verige in cistatina C pri uravnavanju cisteinskih proteaz v antigen predstavitvenih celicah
    [Role of p41 isoform of invariant chain and cystatin C in regulating cysteine proteases in antigen-presenting cells]
    2003
  27. Zavašnik-Bergant Valentina; Langerholc Tomaž; Sekirnik Andreja; Schweiger Ana; Turk Vito; Werle Bernd; Kos Janko
    Invariant chain and cathepsins S, L and H in lung tissue and tumours: relation to MCH II-restricted antigen presentation
    2002
  28. Bergant Damijan; Hočevar Marko; Čufer Tanja
    Karcinom Merklovih celic
    2002
  29. Bergant Martina; Ambrožič-Dolinšek Jana; Demšar Tina; Dreo Tanja; Ravnikar Maja; Rupnik Maja; Žel Jana; Camloh Marjana
    Effects of three antibiotics on contaminated callus cultures of pyrethrum (Tanacetum cinerariifolium (Trevir.) Schultz-Bip)
    2002
  30. Zavašnik-Bergant Valentina; Schweiger Ana; Sekirnik Andreja; Golouh Rastko; Turk Vito; Kos Janko
    Distinct roles of p41 invariant chain and cystatin C in human lymph nodes and their relation to MCH class II restricted antigen processing
    2002
  31. Kos Janko; Sekirnik Andreja; Premzl Aleš; Fan Xiao-Hui; Zavašnik-Bergant Valentina; Scweiger Ana; Štefe Ivica; Turk Boris; Bruenner Nils; Werle Bernd
    Cathepsin B and X: similar proteins with distinct role in cancer progression
    2002
  32. Brecelj E; Auersperg M; Bešić N; Grazio S; Hočevar M; Pompe F; Bergant D
    Neoadjuvant chemotherapy in locoregionally advanced Huerthle cell carcinomas of the thyroid
    2002
  33. Zavašnik-Bergant Valentina; Kopitar-Jerala Nataša; Bevec Tadeja; Kos Janko
    Characterization of monoclonal antibodies against MHC class II-associated p41 invariant chain fragment
    2002
  34. Bergant D; Hočevar M; Pompe F; Bešić N
    Disekcije vratnih bezgavk pri diferenciranih rakih ščitnice
    2002
  35. Hočevar M; Pompe F; Bergant D; Bešić N
    Tehnika tiroidektomije
    2002
  36. Bešić N; Pompe F; Bergant D; Hočevar M
    Indikacije za tiroidektomijo
    2002
  37. Pompe F; Bergant D; Bešič N; Hočevar M
    Zdravljenje raka ščitnice
    2002
  38. Bergant Katra; Musek-Lešnik Kristijan
    Šolska neuspešnost med otroki in mladostniki: vzroki - posledice - preprečevanje
    2002
  39. Zavašnik-Bergant Valentina; Langerholc Tomaž; Sekirnik Andreja; Schweiger Ana; Turk Vito; Werle Bernd; Kos Janko
    Invariant chain and cathepsins S,L and H in lung tissue and tumours: relation to MHC II restricted antigen presentation
    2002
  40. Auersperg M; Bešić N; Brecelj E; Pogačnik A; Grazio S; Pompe F; Bergant D; Hočevar M
    Neoadjuvant chemotherapy with vinblastine in locally advanced thyroid carcinoma with follicular pattern
    2001
  41. Bergant Otmar
    Slovenija proti raku: desetletni program 2000 - 2010
    2000
  42. Bergant Damijan
    Medularni rak štitnjače u Sloveniji u razdoblju od 1969. do 1995. godine
    2001
  43. Bergant Otmar
    Ob 30 letnem jubileju boja proti raku
    2001
  44. Štabuc Borut; Primic-Žakelj Maja; Kocijan Andrej; Bergant Otmar; Zdešar Amalija
    Kajenje in rak pri ženskah. 9. seminar "In memoriam dr. Dušana Reje"; 2001 okt; Ljubljana
    2001
  45. Premzl Aleš; Zavašnik-Bergant Valentina; Puizdar Vida; Kos Janko
    The role of cathepsins B, L and D and their endogenous inhibitors stefins A and B in the processes of tumor progression
    2001
  46. Zavašnik-Bergant Valentina; Langerholc Tomaž; Sekirnik Andreja; Schweiger Ana; Turk Vito; Werle Bernd; Kos Janko
    Role of cathepsins and their inhibitors in MHC class II restricted antigen processing
    2001
  47. Zavašnik-Bergant Valentina; Langerholc Tomaž; Golouh Rastko; Schweiger Ana; Sekirnik Andreja; Werle Bernd; Turk Vito; Kos Janko
    Inhibitory p41 and non-inhibitory p31 isoforms of MHC class II-associated invariant chain in human lung tumours and lymph-node tissue
    2001
  48. Premzl Aleš; Fan Xiaohui; Zavašnik-Bergant Valentina; Kopitar-Jerala Nataša; Turk Vito; Kos Janko
    Monoclonal antibody inhibiting cathepsin B proteolytic activity - a new approach towards cancer treatment
    2001
  49. Kos Janko; Premzl Aleš; Zavašnik-Bergant Valentina; Sekirnik Andreja; Krašovec Marta; Cimerman Nina; Werle Bernd
    Distinct role of lysosomal cathepsin in processes of malignant progressions
    2001
  50. Bergant Lev
    Vpliv zdravil, danih materi, na nedonošenčka
    [Influence of drugs, given to mothers, on the premature newborn]
    2001
  51. Auersperg M; Hočevar M; Brecelj E; Bešić N; Pompe F; Bergant D; Žemva Z
    Impact of palpation and fine needle aspiration biopsy (FNAB) of the thyroid on serum thyroglobulin values
    2000
  52. Hočevar M; Bergant D; Auersperg M; Golouh R
    Medullary carcinoma of the thyroid with serotonin production and carcinoid-like syndrome
    2001
  53. Bergant-Dolar Jelka; Žakelj Marija; Ograjenšek Zdravko; Novak-Antolič Živa
    Prostaglandini v patološki spermi
    1976
  54. Petač D; Vomer I; Bergant J; Dolenc A; Rome J; Vojtec I; Belič C
    Pridobivanje in presajanje zarodkov pri govedu
    1985
  55. Auersperg M; Bergant D
    Obdelava rezultatov pri tumorjih ščitnice za obdobje 1973-1983
    1985
  56. Auersperg M; Furlan L; Bergant D; Porenta O; Zorc R; Us-Krašovec M; Pompe F
    Intraarterial chemotherapy in advanced head and neck tumors
    1985
  57. Bergant M
    Jezikovne zadeve
    1985
  58. Božič J; Grčar S; Mencej M; Cigale M; Bajec P; Bergant M; Cimperman V; Dolenc F; Grgič S; Križaj T; Pečjak-Nemec M; Plevelj M; Prijatelj J; Rebek H; Škoberne A; Toth M; Vlahovič A; Zalaznik J
    Samoupravna ureditev socialne politike v Sloveniji
    1984
  59. Bergant D
    Tumerektomija. Prikaz primera
    1983
  60. Petač D; Šketa J; Bergant J; Vomer I
    Nekirurško pridobivanje in presajanje govejih zarodkov v terenskih pogojih
    1982
  61. Žemva Ž; Bergant D; Šuštaršič J
    Določevanje kalcitonina v serumu
    1980
  62. Auersperg M; Šoba M; Porenta O; Erjavec M; Us-Krašovec M; Bergant D; Furlan L
    RATIONAL SCHEDULING INMULTIDRUG CHEMOTHERAPY WITH SYNCHRONIZATION IN ADVANCED SQUAMOUS CELL CARCINOMA OFTHE ORAL CAVITY AND OROPHARYNX
    1979
  63. Bergant M
    VZGOJNE NALOGE DRUžINE
    1981
  64. Bergant D; Auersperg M; Serša G; Žemva Ž
    SERUM THYREOCALCITONIN (TC) AND CARCINOEMBRYONIC ANTIGEN (CEA) LEVELS IN MEDULLARY CARCINOMA OF THE THYROID GLAND
    1981
  65. Vengušt M; Senegačnik J; Vomer I; Grabljevec A; Bergant J
    VITALITY OF THAWED BULL SEMEN AS ASSESSED BY THE THERMORESISTANCE AND CAFFEINE TEST
    1981
  66. Kranjc-Simoneti S; Kalan M; Kancler K; Sernec-Logar B; Turk-Hribar M; Bergant M; Čačinovič-Vogrinčič G; Horvat L; Pogačnik-Toličič S; Rupel S
    NAŠ MALčEK. NEGA, VZGOJA IN RAZVOJ OTROKA OD ROJSTVA DO TREJTEGA LETA STAROSTI
    1980
  67. Auersperg M; Erjavec M; Furlan L; Porenta O; Šabec R; Šoba E; Us-Krašovec M; Bergant D; Matko I; Oblak LJ; Jenko M; Jež M; Kovačič J; Šoberl J; Bizjak M; Červek J; Golouh R; Jančar J; Lamovec J; Pogačnik A; Adamič Š; Zorc R
    PROBLEMI KEMOTERAPIJE TUMORJEV GLAVE IN VRATU
    1980
  68. Auersperg M; Bergant D; Us-Krašovec M; Golouh R; Lamovec J
    POSTOPERATIVNE KOMPLIKACIJE PRI KIRURŠKEM ZDRAVLJENJU TUMORJEV ŠčITNICE
    1980
  69. Belič I; Bergant-Dolar J; Brodnjak D; Mervič M; Šacer N
    TRANSFORMATION OF TOMATINE BY NOCARDIA RESTRICTUS
    1980
  70. Bergant D; Auersperg M; Us-Krašovec M; Žemva A
    IZKUŠNJE PRI DIAGNOSTIFICIRANJU IN ZDRAVLJENJU MEDULARNEGA KARCINOMA ŠčITNICE IN SPREMLJAJOčIH ENDOKRINOPATIJ NA ONKOLOŠKEM INŠTITUTU V LJUBLJANI
    1980
  71. Lavrič M; Bergant-Dolar J; Kopač I
    VZPOSTAVLJANJE LAKTACIJE IN DOJENJE PO PREZGODNJEM PORODU
    1980
  72. Lavrič M; Bergant-Dolar J; Pajntar M
    LAKTACIJA IN DOJENJE
    1979
  73. Bergant D; Auersperg M; Us-Krašovec M; Šoba E
    REZULTATI IAC PRI NAPREDOVALIH TUMORJIH GLAVE IN VRATU
    1979
  74. Auersperg M; Šoba E; Bergant D; Furlan L
    REZULTAT KEMOTERAPIJE NAPREDOVALIH KARCINOMOV USTNE VOTLINE IN OROFARINKSA
    1979
  75. Bergant J
    Z ZEMLJEVIDOM IN KOMPASOM NA POT
    1975
  76. Pajntar M; Lavrič M; Rojšek J; Kladnik S; Bergant-Dolar J
    OSEBNOSTNE KARAKTERISTIKE IN TRAJANJE DOJENJA
    1977
  77. Lavrič M; Kladnik S; Bergant-Dolar J; Pajntar M
    TRAJANJE LAKTACIJE GLEDE NA HORMONSKI STATUS MATERE IN BIOKEMIčNO SESTAVO MLEKA V ZGODNJEM PUERPERIJU
    1977
  78. Pompe-Kirn V; Bergant F; Kmet J; Pompe J; Ravnihar B; Slabe D
    IZDELAVA METODOLOGIJE AVTOMATIZIRANE OBDELAVE PODATKOV V REGISTRU RAKA ZA SR SLOVENIJO - UPORABA RAčUNALNIKA
    1976
  79. Zavašnik-Bergant Valentina
    Imunokemijsko določanje invariantne verige poglavitnega histokompatibilnostnega kompleksa (MCH) II. razreda ter kolokalizacija s katepsinoma L in S v bioloških vzorcih
    [Immunochemical determination of invariant chain associated with major histocompatibility complex (MHC) class II and its co-localization with cathepsins L and S in biological samples]
    2000
  80. Zavašnik-Bergant Valentina; Kos Janko
    Vloga invariantne verige in cisteinskih proteinaz v antigen predstavitvenih celicah
    [Role of invariant chain and cysteine proteinases in antigen presenting cells]
    2000
  81. Zavašnik-Bergant Valentina; Sekirnik Andreja; Kreft Marko; Golouh Rastko; Turk Vito; Kos Janko
    Co-localization of MHC class 2-associated p41 invariant chain and cathepsin S in human lymph nodes
    2000
  82. Kos Janko; Sekirnik Andreja; Zavašnik-Bergant Valentina; Cimerman Nina; Lah Tamara; Turk Vito; Kayser Klaus; Stremmer Anja; Fiehn Walter; Werle Bernd
    Cathepsin S in cancer patients: relation to prognosis and immune response
    2000
  83. Glavač D; Caserman S; Bergant D; Ravnik-Glavač M
    Mutations in the RET proto-oncogene in Slovenian families with multiple endocrine neoplasia type 2
    2000
  84. Glavač D; Caserman S; Gorinšek B; Bergant D; Ravnik-Glavač M
    Molecular genetic analysis of Slovenian families with hereditary multiple endocrine neoplasia type 2 (MEN 2A, MEN 2B and FMTC)
    2000
  85. Kersnik-Bergant Maja; Stropnik Nada; Marolt-Meden Biserka
    Imam otroka - imam pravice: priročnik za starše
    1997
  86. Caserman Simon; Gorinšek B; Bergant D; Ravnik-Glavač M; Glavač D
    C618R mutation in the RET proto-oncogene in a Slovenian kindred with a medulary thyroid carcinoma (FMTC) and Hirschprung disease
    1999
  87. Štabuc Borut; Čufer Tanja; Bergant Otmar; Kocijan Andrej; Primic-Žakelj Maja; Ulčar Metka
    Rak pri moškem. 7. seminar "In memoriam dr. Dušana Reje"
    1999
  88. Bergant Otmar; Kocijan A
    Poročilo o delu Zveze slovenskih društev in regijskih društev za boj proti raku za leto 1997
    1998
  89. Bergant Otmar; Štabuc B; Primic-Žakelj M
    Poročilo o delu Zveze slovenskih društev in regijskih društev za boj proti raku za leto 1998
    1999
  90. Bergant Otmar
    Organizacija pregledov dojk in zdravstvena vzgoja žena
    1998
  91. Caserman Simon; Gorinšek Benjamin; Bergant Damijan; Ravnik-Glavač Metka; Glavač Damjan
    C618R mutation in the RET proto-oncogene in a Slovenian kindred with a familial medulary thyroid carcinoma (FMTC) and hirschsprung disease
    1999
  92. Kersnik-Bergant Maja
    O starosti, staranju in aktivnosti starejših - sociološki pogled
    [About old age, ageing and activity of older people: a sociological point of view]
    1999
  93. Bergant Damijan
    Medularni rak ščitnice
    1998
  94. Bešić N; Auersperg M; Pompe F; Bergant D; Hočevar M; Brecelj E
    Karcinom ščitnice v starosti
    1998
  95. Us-Krašovec M; Auersperg M; Bergant D; Golouh R; Kloboves-Prevodnik V
    Medullary carcinoma of the thyroid gland: diagnostic cytopathological characteristics
    1998
  96. Glavač D; Bergant D; Caserman S; Gorinšek B; Ravnik-Glavač M
    Molecular genetic analysis of RET-receptor tyrosine kinease gene mutations in different neoplastic phenotypes
    1998
  97. Glavač Damjan; Potočnik U; Bergant D; Ravnik-Glavač M
    Molecular genetic analysis of multiple endocrine neoplasia type 2 in Slovenian population
    1998
  98. Bergant Damjan
    Medularni rak ščitnice
    1998
  99. Potočnik U; Ravnik-Glavač M; Bergant D; Glavač D
    Molecular genetic analysis of multiple endocrine neoplasia type II and von Hippel-Lindau disease
    1997
  100. Lukič Franc; Kocijan Andrej; Demšar France; Bergant Otmar
    Zbornik: onkološki vikend; 1992 nov 20-21; Šmarješke Toplice
    1992

   1 101 201  


New search      Comments      Top of page Institute for Biostatistics and Medical Informatics